Welcome to AnavexTM Life Sciences Corp.

Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer.

2016 CTAD Presentation
9-Months and 12-Months Safety and Exploratory Efficacy Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease Patients.

Anavex reports Fiscal 2016 Financial Results and Clinical Progress. Recorded Dec 12, 2016


Anavex rings the Nasdaq Stock Market Closing Bell on Oct. 30, 2015



girls with guns frozen dawn slot